© The Rockefeller University Press, 0022-1007/1997/12/1957/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 12, December 15, 1997 1957-1963
Association with FcR
Is Essential for Activation Signal through NKR-P1 (CD161) in Natural Killer (NK) Cells and NK1.1+ T Cells
Noriko Arase*,
Hisashi Arase*,
Seung Yong Park*,
Hiroshi Ohno*,
Chisei Ra
, and
Takashi Saito*
From the * Division of Molecular Genetics, Center for Biological Science, Chiba University School of Medicine, Chiba 260, Japan; and the Department of Immunology, Juntendo University School of Medicine, Tokyo 113, Japan
 |
Abstract
|
|---|
Natural killer (NK) cells exhibit cytotoxicity against variety of tumor cells and virus-infected cells without prior sensitization and represent unique lymphocytes involved in primary host defense. NKR-P1 is thought to be one of NK receptors mediating activation signals because cross-linking of NKR-P1 activates NK cells to exhibit cytotoxicity and IFN-
production. However, molecular mechanism of NK cell activation via NKR-P1 is not well elucidated. In this study, we analyzed the cell surface complex associated with NKR-P1 on NK cells and found that NKR-P1 associates with the FcR chain which is an essential component of Fc receptors for IgG and IgE. The association between FcR and NKR-P1 is independent of Fc receptor complexes. Furthermore, NK cells from FcR-deficient mice did not show cytotoxicity or IFN- production upon NKR-P1 cross-linking. Similarly, NK1.1+ T cells from FcR-deficient mice did not produce IFN- upon NKR-P1 crosslinking. These findings demonstrate that the FcR chain plays an important role in activation of NK cells via the NKR-P1 molecule.
Address correspondence to Takashi Saito, Division of Molecular Genetics, Center for Biological Science, Chiba University School of Medicine, 1-8-1 Inohana, Chuou-ku, Chiba 260, Japan. Phone: 81 43 226-2197; FAX: 81 43 222-1791; E-mail: saito{at}med.m.chiba-u.ac.jp
NK cells play a pivotal role in protective immunity. Especially, NK cells are involved in the earliest stage of immune response because they can exhibit cytotoxicity or cytokine production without prior sensitization (1). Therefore, it is important to elucidate the mechanism of antigen recognition by NK cells to understand innate immunity. Recent analyses have revealed that various types of receptors are involved in the regulation of NK cell activation (2, 3). Among these, the NKR-P1 molecule is thought to be one of NK receptors which mediates NK cell activation because cross-linking of NKR-P1 induces various activation signals such as, Ca2+ flux, PI turnover and lymphokine production (4, 5). The NKR-P1 was originally cloned from rat NK cells (4, 5), and subsequently cloned from mouse and human (6, 7). In mouse NK cells, NK1.1, a specific marker of mouse NK cells, is one of NKR-P1 family molecules, NKR-P1C (8).
NK cells exhibit cytotoxicity and IFN- production upon cross-linking of NKR-P1 molecule with specific mAb (4, 5, 9, 10). Indeed, introduction of NKR-P1 into a NKR-P1-deficient NK cell line restored cytotoxicity against certain tumor cell targets (11). Furthermore, anti–NKR-P1 mAb blocked the cytotoxicity by the NKR-P1–transfected NK cells (11). Therefore, NKR-P1 seems to be involved in the antigen recognition by NK cells. Although the exact ligand for NKR-P1 remains to be determined, NKR-P1 belongs to the C-type lectin superfamily and certain carbohydrates expressed on target cells are postulated to be recognized by the NKR-P1 molecule (12).
In respect to the signaling pathway for NKR-P1, it has been shown that NKR-P1 crosslinking stimulates PI turnover and raises intracellular Ca2+ concentration (13). In addition, NKR-P1 possesses a p56lck-binding motif which is represented by YxxL sequence and indeed the association of p56lck to NKR-P1 was recently reported (14). However, essential components for NK cell activation via the NKR-P1 molecule have not been elucidated. In the present study, we analyzed the cell surface complex associated with the NKR-P1 molecule and found that the FcR chain is associated with NKR-P1. Furthermore, the analysis of NK cells from FcR-deficient mice revealed that the FcR chain is essential for mediating activation signals via NKR-P1.
|
Materials and Methods
|
|---|
Mice.
FcR-deficient (–/–)1 mice with C57BL/6 background were established by gene targeting using a C57BL/6 origin ES cell line BL6/III (15) in our laboratory (Park, S.Y. et al., manuscript submitted, 16, 17) and maintained in our animal facility in SPF condition.
NK Cell Preparation.
NK cells were purified as previously described (18). In brief, NK cells were purified from spleen of 6–8-wk-old C57BL/6 mice. Splenocytes were mixed with anti-CD4 mAb (GK1.5) and anti-CD8 mAb (53.6.7), and incubated with magnetic beads (Advanced Magnetics, Inc., Cambridge, MA) coupled with goat anti–mouse IgG Ab and goat anti–rat IgG Ab (Cappel, Organon Teknika Co., West Chester, PA) to remove surface Ig (sIg)+ B cells and CD4+ and CD8+ T cells. The residual cells were then stained with PE-anti-NK1.1 (PK136) mAb and FITC-anti-CD3
(145-2C11) mAb (Pharmingen, San Diego, CA) and NK1.1+ CD3– cells were sorted by FACStarplus® (Becton Dickinson, Mountain View, CA). The purified NK cells were cultured in RPMI-1640 supplemented with 10% FCS, kanamycin (100 µg/ml) and 5 x 10–5 M 2-ME in the presence of 1,000 U/ml human recombinant IL-2 (kindly provided by Dr. Junji Hamuro, Ajinomoto Co. Inc., Kawasaki, Japan) for 5 d.
Flow Cytometric Analysis of NK Cells.
CD4–CD8–sIg– splenocytes prepared as described above were cultured for 4 d in the presence of 1,000 U/ml IL-2. The cultured cells were first stained with FITC–anti-FcRIII (2.4G2) mAb. Then, the cells were mixed with Biotin–anti-CD3 and PE–anti-NK1.1 mAbs followed by Quantum-red streptavidin (Sigma Chem. Co., St. Louis, MO).
NK1.1+ T Cell Preparation.
Basically, NK1.1+ T cells were prepared as previously described (10). Thymocytes were treated with anti-HSA mAb (J11d) followed by complement treatment. The resultant cells were incubated with anti-CD8 and anti–MEL-14 mAb. Thereafter, CD8+ MEL-14+ cells were removed by use of magnetic beads coupled with goat anti–rat IgG Ab. The residual cells were cultured for 3 d in the presence of 1,000 U/ml IL-2. Thereafter, cells were stained with PE–anti-NK1.1 mAb and FITC–anti-CD3 mAb. The stained cells were sorted into NK1.1+CD3+ cells. The sorted cells were further cultured for 2 d in the presence of 1,000 U/ml IL-2 and used for functional analysis.
Surface Biotinylation, Immunoprecipitation and Western Blotting.
Cells were surface biotinylated as previously described (19). Biotinylated cells were lysed with a lysis buffer containing 1% digitonin, 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM PMSF, 10 mM iodoacetamide, at a concentration of 1 x 107 cell/ml. Immunoprecipitation was performed with anti-CD3 or anti-NK1.1 mAbs. Immunoprecipitates were separated on two-dimensional nonreducing and reducing SDS-PAGE and transferred onto a polyvinylidene difluoride (PVDF) membrane (Immobilon-P; Millipore Corporation, Bedford, MA). The biotinylated proteins were detected using streptavidin-peroxidase (VECSTAIN Elite ABC kit; Vector Laboratories Incorporated, Burlingame, CA), the ECL system (Amersham International, Buckinghamshire, England), and autoradiography. After termination of chemiluminescence, the membrane was blotted with anti-FcR Ab followed by peroxidase-labeled anti–rabbit Ab (Amersham) and detected by the ECL system.
NKR-P1 and TCR Stimulation.
(Fab)'2 fragment of anti-NK1.1 mAb was immobilized on a 96-well flat-bottomed culture plate (Coaster, Cambridge, MA) by incubating for 2 h at 37°C at a concentration of 50 µg/ml in PBS. Similarly, anti–TCR-β mAb (H57-597) was immobilized at a concentration of 100 µg/ml. 1 x 105 NK cells cultured for four days in the presence of IL-2 were stimulated with the immobilized anti-NK1.1 mAb, or with recombinant mouse IL-12 (4.9 x 106 U/mg, generously supplied from Genetics Institute, Inc., Cambridge, MA) for 2 d.
Measurement of IFN- and IL-4.
IFN- and IL-4 in the culture supernatant was measured by ELISA with standard protocol. Anti–IFN- (R4-6A2) and anti–IL-4 (BVD4-1D11) mAb was coated to capture IFN- and IL-4 and the captured IFN- and IL-4 were detected with biotinylated anti–IFN- (XMG1.2) and anti–IL-4 (BVD6-24G2) mAbs. These antibodies were purchased from Pharmingen. Concentrations of IFN- and IL-4 were determined with recombinant IFN- and IL-4 as a standard.
Redirected Cytotoxicity of NK Cells.
Cytotoxic assay was done basically as previously described (20). Briefly, freshly isolated CD4– CD8– HSA– sIg– population was used as NK cell enriched population. About 50% of this population expressed the NK1.1 molecule. These NK cells were incubated at 4°C for 30 min in the presence or absence of anti-NK1.1 mAb. Thereafter, 51Cr-labeled FcR-expressing P815 cells were added and cultured at 37°C for 4 h and analyzed the amount of Cr51 released in the culture supernatant. Specific cytotoxicity was calculated as previously described (20).
|
Results
|
|---|
To elucidate signaling pathways for NK cell activation through NKR-P1, we analyzed the NKR-P1-associated complex on the cell surface using an NK1.1-expressing T cell line CTLL-2. CTLL-2 cells were surface-biotinylated and the cell lysate was immunoprecipitated with anti-NK1.1 or anti-CD3 mAbs, followed by analysis on two dimensional nonreducing and reducing SDS-PAGE.
As shown in Fig. 1 A, immunoprecipitation with anti-NK1.1 mAb revealed that a 9-kD homodimer was coprecipitated with NK1.1 molecule. In contrast, when the TCR complex was precipitated with anti-CD3 mAb, CD3
homodimers, CD3-FcR heterodimers and a small amount of FcR homodimers were observed as previously reported (21). Interestingly, the 9-kD homodimers coprecipitated with NK1.1 appeared to be identical to FcR within the TCR complex. Indeed, the homodimers coprecipitated with NK1.1 were blotted with anti-FcR Ab similarly to FcR observed in the CD3-immunoprecipitates (Fig. 1 B). The association of the FcR chain with the NKR-P1 molecule was also observed in a rat NK cell line, RNK-16 (data not shown). We next analyzed normal NK cells to generalize the physical association between FcR and NKR-P1 in normal NK cell population. Similar to CTLL-2, when NK1.1 was immunoprecipitated from IL-2 activated NK cells, the FcR homodimer was coprecipitated with NK1.1 (Fig. 2). Collectively, these data indicate that the association of FcR with NKR-P1 is generally observed for NK cells in vivo.
To elucidate the physiological role of the association between FcR and NKR-P1 particularly on signal transduction in NK cells, NK cells were prepared from –/– mice and analyzed for NKR-P1 expression and NKR-P1–mediated NK cell activation. When CD4–CD8–sIg– splenocytes from –/– mice were stained with anti-NK1.1 and anti-CD3 mAbs, normal development of NK cells (NK1.1+CD3–) was observed (data not shown). When expression of FcRIII on IL-2–expanded NK cells was analyzed, NK cells from –/– mice did not express FcRIII (Fig. 3). In addition, the expression level of NK1.1 on the cell surface of IL-2–expanded NK cells from –/– mice was significantly lower than that of NK cells from +/+ and +/– mice. However, the difference of NK1.1 expression between –/– and +/– mice was marginal when freshly isolated NK cells were analyzed (data not shown). This suggested that FcR is not absolutely required for but affects the surface expression of the NKR-P1 molecule.
Recently, we have shown that cross-linking of NKR-P1 on NK cells with anti-NK1.1 mAb induced not only cytotoxicity but also IFN- production (10). Thus, we stimulated purified NK cells from –/– mice with immobilized F(ab)'2 fragment of anti-NK1.1 mAb in order to avoid the binding of the Ab to Fc receptors, and measured the amount of IFN- produced in the culture supernatant. Surprisingly, NK cells from –/– mice did not produce IFN- at all upon NKR-P1 cross-linking, whereas NK cells from +/+ mice produced a large amount (Fig. 4). In contrast, NK cells from both –/– and +/+ mice produced almost equal amount of IFN- upon IL-12 stimulation. This suggests that the defect of IFN- production upon NKR-P1 cross-linking by NK cells from –/– mice is not due to the inability of IFN- production but the signaling defect via NKR-P1.
Because NK1.1+ T cells also produce IFN- but not IL-4 upon NKR-P1 cross-linking (10), we also analyzed the function of NK1.1+ T cells in –/– mice. As we have previously reported (22), NK1.1+ T cells develop normally in –/– mice. NK1.1+ T cells were prepared from +/+ and –/– mice and stimulated with immobilized anti-NK1.1 mAb (Fig. 5). Similar to NK cells, NK1.1+ T cells from –/– mice did not produce IFN- upon NKR-P1 cross-linking whereas these cells from +/+ mice produced a significant amount of IFN-. In contrast to the stimulation through NKR-P1, NK1.1+ T cells from both +/+ and –/– mice produced IFN- and IL-4 upon TCR crosslinking. These observations demonstrate that the FcR chain is required for IFN- production via NKR-P1 cross-linking both in NK cells and NK1.1+ T cells.
We also investigated the involvement of FcR in the NKR-P1–mediated cytotoxicity of NK cells. Since NKR-P1 is known to induce redirected cytotoxicity against FcR-expressing cells, we analyzed cytotoxicity of NK cells against FcR-expressing P815 cells in the presence of anti-NK1.1 mAb (Fig. 6). NK cells from +/+ and +/– mice showed increased cytotoxicity against P815 cells in the presence of anti-NK1.1 mAb, whereas NK cells from –/– mice failed to enhance cytotoxicity. These results demonstrate that FcR is involved in both IFN- production and cytotoxicity upon stimulation through the NKR-P1 molecule.
The failure of NK cell activation through NKR-P1 in –/– mice is likely due to a defect in signaling pathway of the NKR-P1 molecule. However, since the NK1.1 expression on the cell surface of NK cells from –/– mice is slightly lower than that of +/– and +/+ mice, it might be attributed to the low expression of the cell surface NKR-P1. To clarify these possibilities, we prepared two populations of NK cells from normal mice expressing low or high level of NKR-P1 (NKR-P1lo and NKR-P1hi, respectively) by cell sorting. The expression level of NKR-P1 on the NKR-P1lo population was almost identical to that of NK cells from –/– mice. (Fig. 7, A and B). Then, we stimulated these NK cell populations with immobilized anti-NK1.1 mAb. NKR-P1lo NK cells from +/+ mice produced significant amount of IFN- upon NKR-P1 cross-linking, although the amount of IFN- was lower than that by NKR-P1hi NK cells (Fig. 7 C). In contrast, NK cells from –/– mice did not produce any detectable level of IFN- upon NKR-P1 cross-linking. These observations confirm the crucial role of FcR in signaling pathway through NKR-P1 for NK activation and also demonstrate that FcR is partly involved in the expression of the cell surface NKR-P1.
|
Discussion
|
|---|
FcR was originally identified in the FcRI complex and found to play an essential role in the expression and signaling of FcRI (23). FcR was also found to be required for the expression and function of FcRI, FcRIII and Fc
R (24, 25). On the other hand, we found that FcR also associates with the TCR complexes in two types of T cells. One is T cells in epithelia such as CD8+ TCR-/
+ intestinal intraepitherial lymphocytes and TCR /+ dendritic epidermal cells and the association with FcR in these cells was shown in vivo from the analysis of CD3-deficient mice (26). The second population is NK1.1+ TCR-/β+ T cells. (22). However, these T cells obtained from –/– mice showed no clear defect in function upon TCR activation, although the expression level of the TCR complex was slightly decreased (27). Accordingly, it is striking that NK cells and NK1.1+ T cells from –/– mice show no response upon NKR-P1 cross-linking in spite of normal development. This finding suggests that CD3 expressed in NK cells and NK1.1+ T cells can not be replaced for FcR in signaling through NKR-P1, because NKR-P1 bind only to FcR dimers but not to CD3 homodimers or CD3-FcR heterodimers. In contrast, T cells show no functional defect in –/– mice probably because the TCR complexes can utilize both CD3 and FcR and CD3 can replace for FcR in the TCR complexes of –/– mice.
FcRIII which is associated with FcR is known to activate NK cells upon cross-linking. Therefore, there is a possibility that NKR-P1 associates with FcRIII on the cell surface and delivers activating signal through FcR which is coupled with FcRIII. However, this is unlikely because of two reasons. One is that FcRIII was not expressed on the cell surface of CTLL-2 (data not shown), whereas the association between FcR and NKR-P1 was readily detected in the CTLL-2 (Fig. 1). Second, we used the (Fab)'2 fragment of anti-NK1.1 mAb for cross-linking of NKR-P1 and thus it is unlikely that immobilized anti-NK1.1 mAb activated FcRIII. Taken together, the association of FcR with NKR-P1 is essentially independent of FcRIII.
Recent analysis revealed that activation of NK cells is negatively regulated by several killer inhibitory receptors (KIR) possessing immunoreceptor tyrosine-based inhibition motif (ITIM) (28, 29). These receptors such as p58, NKG2, and Ly49 recognize specific MHC class I molecule and deliver inhibitory signal for the cytotoxicity by NK cells (30–32). Furthermore, association of SHP-1 phosphatase with ITIM is important for the inhibition of NK cell activation (28, 29). Although the coprecipitation of CD3 or FcR with p58 was suggested, functional significance remained unclear (33). On the other hand, only a few receptors which deliver positive signal for NK cell activation have been identified such as NKR-P1 and CD94/NKG2-C (34) and the molecular mechanism of NK cell activation through these receptors remains unclear. Under these circumstances, it is noteworthy that FcR, a signal transducing chain possessing immunoreceptor tyrosine-based activation motif (ITAM), is involved in signal transduction through NKR-P1. Because Syk tyrosine kinase interacts with the phosphorylated ITAM of FcR and is involved in NK cell activation through FcR (35, 36), it is likely that Syk also mediates the activating signal through NKR-P1 in NK cells. Furthermore, it has been shown that Lck directly associates with NKR-P1 (14). Taken together, both Syk and Lck seem to play an important role in mediating activation signals through NKR-P1 in NK cells.
Although the NKR-P1 molecule belongs to the C-type lectin superfamily and has been shown to have affinity to specific carbohydrates (12), the exact function of NKR-P1 has remained unclear. This is partly because antibodies against mouse or rat NKR-P1 do not block cytotoxicity of NK cells against YAC-1, a NK-sensitive target cell line. In addition, NK cells from –/–– mice showed normal cytotoxicity against representative NK targets (data not shown). However, the failure of blocking with anti–NKR-P1 mAb can be explained by the possible redundancy of NKR-P1 family molecules on NK cells. Indeed, recent observation that introduction of NKR-P1 into a NKR-P1–deficient NK cell line restored cytotoxicity against specific tumor cell targets and the restored cytotoxicity was blocked by anti– NKR-P1 mAb (11) strongly suggested that NKR-P1 is involved in the recognition of specific target molecules on NK cells. A couple of reports demonstrating that anti-NK1.1 mAb blocked cytotoxicity of NK cells against specific targets also support this idea (37, 38). Further analysis of NK cells in –/– mice may elucidate novel function of NKR-P1 molecule in the host defence.
|
Acknowledgments
|
|---|
We would like to thank Dr. J. Hamuro for providing IL-2, Ms. C. Sakuma and Ms. R. Siina for technical assistance, and Ms. H. Yamaguchi for secretarial assistance.
This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education to H. Arase and T. Saito.
Submitted: 28 July 1997
Revised: 3 October 1997
The first two authors contributed equally to this work.
1 Abbreviations used in this paper: –/–, FcR-deficient; ITAM, immunoreceptor tyrosine-based activation motif; ITIM, immunoreceptor tyrosine-based inhibition motif; KIR, killer inhibitory receptors. 
|
References
|
|---|
1 Scott P & Trinchieri G. The role of natural killer cells in host-parasite interactions, Curr Opin Immunol, 1995, 7, 34–40.[Medline]
2 Yokoyama WM. Natural killer cell receptors, Curr Opin Immunol, 1995, 7, 110–120.[Medline]
3 Raulet DH & Held W. Natural killer cell receptors: the offs and ons of NK cell recognition, Cell, 1995, 82, 697–700.[Medline]
4 Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB & Hiserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells, J Exp Med, 1989, 169, 1373–1389.[Abstract/Free Full Text]
5 Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC & Trucco M. NKR-P1, a signal transduction molecule on natural killer cells, Science, 1990, 249, 1298–1300.[Abstract/Free Full Text]
6 Giorda R & Trucco M. Mouse NKR-P1: a family of genes selectively coexpressed in adherent lymphokine-activated killer cells, J Immunol, 1991, 147, 1701–1708.[Abstract]
7 Lanier LL, Chang C & Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes, J Immunol, 1994, 153, 2417–2428.[Abstract]
8 Ryan JC, Turck J, Niemi EC, Yokoyama WM & Seaman WE. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules, J Immunol, 1992, 149, 1631–1635.[Abstract]
9 Karlhofer FM & Yokoyama WM. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2 activated NK cells possess additional specific stimulation pathways, J Immunol, 1991, 146, 3662–3673.[Abstract]
10 Arase H, Arase N & Saito T. Interferon- production by natural killer cells and NK1.1+T cells upon NKR-P1 cross-linking, J Exp Med, 1996, 183, 2391–2396.[Abstract/Free Full Text]
11 Ryan JC, Niemi EC, Nakamura MC & Seaman WE. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity, J Exp Med, 1995, 181, 1911–1915.[Abstract/Free Full Text]
12 Bezouska K, Yuen C-T, O'Brien J, Childs RA, Chai W, Lawson AM, Drbal K, Fiserova A, Pospisil M & Feizi T. High affinity oligosaccharide ligands for NKR-P1 protein that elicits natural killer cell activation and cytotoxicity, Nature, 1994, 372, 150–157.[Medline]
13 Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC & Seaman WE. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium, J Immunol, 1991, 147, 3244–3250.[Abstract]
14 Campbell KS & Giorda R. The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues, Eur J Immunol, 1997, 27, 72–77.[Medline]
15 Ledermann B & Burki K. Establishment of a germ-line competent C57BL/6 embryonic stem cell line, Exp Cell Res, 1991, 197, 254–258.[Medline]
16 van Vugt MJ, Heijnen AF, Capel PJ, Park SY, Ra C, Saito T, Verbeek JS & van de Winkel JG. FcR-chain is essential for both surface expression and function of human FcRI (CD64) in vivo, Blood, 1996, 87, 3593–3599.[Abstract/Free Full Text]
17 Poole A, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JGJ, Saito T, Tybulewicz VLJ & Watson SP. The Fc receptor -chain and the tyrosine kinase syk are essential for activation of mouse platelets by collagen, EMBO (Eur Mol Biol Organ) J, 1997, 16, 2333–2341.[Medline]
18 Arase H, Arase N & Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells, J Exp Med, 1995, 181, 1235–1238.[Abstract/Free Full Text]
19 Ono S, Ohno H & Saito T. Rapid turnover of the CD3 chain independent of the TCR-CD3 complex in normal T cells, Immunity, 1995, 2, 639–644.[Medline]
20 Arase H, Arase-Fukushi N, Good RA & Onoé K. Lymphokine-activated killer cell activity of CD4– CD8– TCRβ+thymocytes, J Immunol, 1993, 151, 546–555.[Abstract]
21 Orloff DG, Ra C, Frank SJ, Klausner RD & Kinet JP. Family of disulfide-linked dimers containing the and 
chains of the T-cell receptor and the chain of Fc receptors, Nature, 1990, 347, 189–191.[Medline]
22 Arase H, Ono S, Arase N, Park SY, Wakizaka K, Watanabe H, Ohno H & Saito T. Developmental arrest of NK1.1+ T cell receptor (TCR)-/β+ T cells and expansion of NK1.1+ TCR-/+T cell development in CD3-deficient mice, J Exp Med, 1995, 182, 891–895.[Abstract/Free Full Text]
23 Blank U, Ra C, Miller L, White K, Metzger H & Kinet JP. Complete structure and expression in transfected cells of high affinity IgE receptor, Nature, 1989, 337, 187–189.[Medline]
24 Ra C, Jouvin M-H, Blank U & Kinet JP. A macrophage Fc receptor and the mast cell receptor for IgE share an identical subunit, Nature, 1989, 341, 752–754.[Medline]
25 Ravetch JV & Kinet JP. Fc receptors, Ann Rev Immunol, 1991, 9, 457–492.[Medline]
26 Ohno H, Ono S, Hirayama N, Shimada S & Saito T. Preferential usage of the Fc receptor chain in the T cell antigen receptor complex by / T cells localized in epithelia, J Exp Med, 1994, 179, 365–369.[Abstract/Free Full Text]
27 Park SY, Arase H, Wakizaka K, Hirayama N, Masaki S, Sato S, Ravetch JV & Saito T. Differential contribution of the FcR- chain to the surface expression of the T cell receptor among T cells localized in epithelia: analysis of FcR--deficient mice, Eur J Immunol, 1995, 25, 2107–2110.[Medline]
28 Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A et al.. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases, J Immunol, 1996, 156, 4531–4534.[Abstract]
29 Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP & Long EO. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor, Immunity, 1996, 4, 77–85.[Medline]
30 Colonna M & Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells, Science, 1995, 268, 405–408.[Abstract/Free Full Text]
31 Phillips JH, Gumperz JE, Parham P & Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes, Science, 1995, 268, 403–405.[Abstract/Free Full Text]
32 Karlhofer FM, Ribaudo RK & Yokoyama WM. MHC class I alloantigen specificity of Ly-49+IL-2 activated natural killer cells, Nature, 1992, 358, 66–70.[Medline]
33 Bottino C, Vitale M, Olcese L, Sivori S, Morelli L, Augugliaro A, Ciccone E, Moretta L & Moretta A. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 chain, FcRI chain and the p56lckkinase, Eur J Immunol, 1994, 24, 2527–2534.[Medline]
34 Mason LH, Anderson SK, Yokoyama WM, Smith HR, Winkler-Pickett R & Ortaldo JR. The Ly-49D receptor activates murine natural killer cells, J Exp Med, 1996, 184, 2119–2128.[Abstract/Free Full Text]
35 Ting AT, Dick CJ, Schoon RA, Karnitz LM, Abraham RT & Leibson PJ. Interaction between lck and syk family tyrosine kinases in Fc receptor-initiated activation of natural killer cells, J Biol Chem, 1997, 270, 16415–16421.[Medline]
36 Shiue L, Zoller MJ & Brugge JS. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE, J Biol Chem, 1995, 270, 10498–10502.[Abstract/Free Full Text]
37 Kung SKP & Miller RG. The NK1.1 antigen in NK-mediated F1antiparent killing in vitro, J Immunol, 1995, 154, 1624–1633.[Abstract]
38 Takeda K & Dennert G. Demonstration of MHC class I-specific cytolytic activity in IL-2-activated NK1+CD3+cells and evidence of usage of T and NK cell receptors, Transplantation, 1994, 58, 496–504.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
-
Aust, J. G., Gays, F., Mickiewicz, K. M., Buchanan, E., Brooks, C. G.
(2009). The Expression and Function of the NKRP1 Receptor Family in C57BL/6 Mice. J. Immunol.
183: 106-116
[Abstract]
[Full Text]
-
Whittaker, G. C., Burshtyn, D. N., Orr, S. J., Quigley, L., Hodge, D. L., Pascal, V., Zhang, W., McVicar, D. W.
(2008). Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire. Blood
112: 2869-2877
[Abstract]
[Full Text]
-
Guo, H., Samarakoon, A., Vanhaesebroeck, B., Malarkannan, S.
(2008). The p110{delta} of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. JEM
205: 2419-2435
[Abstract]
[Full Text]
-
MacFarlane, A. W. IV, Yamazaki, T., Fang, M., Sigal, L. J., Kurosaki, T., Campbell, K. S.
(2008). Enhanced NK-cell development and function in BCAP-deficient mice. Blood
112: 131-140
[Abstract]
[Full Text]
-
Coudert, J. D., Scarpellino, L., Gros, F., Vivier, E., Held, W.
(2008). Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood
111: 3571-3578
[Abstract]
[Full Text]
-
Hidano, S., Sasanuma, H., Ohshima, K., Seino, K.-i., Kumar, L., Hayashi, K., Hikida, M., Kurosaki, T., Taniguchi, M., Geha, R. S., Kitamura, D., Goitsuka, R.
(2008). Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN-{gamma} production. Int Immunol
20: 345-352
[Abstract]
[Full Text]
-
Wang, J., Shiratori, I., Satoh, T., Lanier, L. L., Arase, H.
(2008). An Essential Role of Sialylated O-Linked Sugar Chains in the Recognition of Mouse CD99 by Paired Ig-Like Type 2 Receptor (PILR). J. Immunol.
180: 1686-1693
[Abstract]
[Full Text]
-
Deniz, G., Erten, G., Kucuksezer, U. C., Kocacik, D., Karagiannidis, C., Aktas, E., Akdis, C. A., Akdis, M.
(2008). Regulatory NK Cells Suppress Antigen-Specific T Cell Responses. J. Immunol.
180: 850-857
[Abstract]
[Full Text]
-
Walzer, T., Blery, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S., Andre, P., Gauthier, L., Daniel, L., Chemin, K., Morel, Y., Dalod, M., Imbert, J., Pierres, M., Moretta, A., Romagne, F., Vivier, E.
(2007). Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA
104: 3384-3389
[Abstract]
[Full Text]
-
Urich, E., Gutcher, I., Prinz, M., Becher, B.
(2006). Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors. Proc. Natl. Acad. Sci. USA
103: 18697-18702
[Abstract]
[Full Text]
-
Wines, B. D., Trist, H. M., Ramsland, P. A., Hogarth, P. M.
(2006). A Common Site of the Fc Receptor {gamma} Subunit Interacts with the Unrelated Immunoreceptors Fc{alpha}RI and Fc{epsilon}RI. J. Biol. Chem.
281: 17108-17113
[Abstract]
[Full Text]
-
Sasanuma, H., Tatsuno, A., Hidano, S., Ohshima, K., Matsuzaki, Y., Hayashi, K., Lowell, C. A., Kitamura, D., Goitsuka, R.
(2006). Dual function for the adaptor MIST in IFN-{gamma} production by NK and CD4+NKT cells regulated by the Src kinase Fgr. Blood
107: 3647-3655
[Abstract]
[Full Text]
-
Pozo, D., Vales-Gomez, M., Mavaddat, N., Williamson, S. C., Chisholm, S. E., Reyburn, H.
(2006). CD161 (Human NKR-P1A) Signaling in NK Cells Involves the Activation of Acid Sphingomyelinase. J. Immunol.
176: 2397-2406
[Abstract]
[Full Text]
-
Maeda, M., Carpenito, C., Russell, R. C., Dasanjh, J., Veinotte, L. L., Ohta, H., Yamamura, T., Tan, R., Takei, F.
(2005). Murine CD160, Ig-Like Receptor on NK Cells and NKT Cells, Recognizes Classical and Nonclassical MHC Class I and Regulates NK Cell Activation. J. Immunol.
175: 4426-4432
[Abstract]
[Full Text]
-
Xie, X., He, H., Colonna, M., Seya, T., Takai, T., Croy, B. A.
(2005). Pathways Participating in Activation of Mouse Uterine Natural Killer Cells During Pregnancy. Biol. Reprod.
73: 510-518
[Abstract]
[Full Text]
-
Tassi, I., Presti, R., Kim, S., Yokoyama, W. M., Gilfillan, S., Colonna, M.
(2005). Phospholipase C-{gamma}2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors. J. Immunol.
175: 749-754
[Abstract]
[Full Text]
-
Ljutic, B., Carlyle, J. R., Filipp, D., Nakagawa, R., Julius, M., Zuniga-Pflucker, J. C.
(2005). Functional Requirements for Signaling through the Stimulatory and Inhibitory Mouse NKR-P1 (CD161) NK Cell Receptors. J. Immunol.
174: 4789-4796
[Abstract]
[Full Text]
-
Giroux, M., Denis, F.
(2005). CD1d-unrestricted human NKT cells release chemokines upon Fas engagement. Blood
105: 703-710
[Abstract]
[Full Text]
-
Ishikawa, S., Arase, N., Suenaga, T., Saita, Y., Noda, M., Kuriyama, T., Arase, H., Saito, T.
(2004). Involvement of FcR{gamma} in signal transduction of osteoclast-associated receptor (OSCAR). Int Immunol
16: 1019-1025
[Abstract]
[Full Text]
-
Carlyle, J. R., Jamieson, A. M., Gasser, S., Clingan, C. S., Arase, H., Raulet, D. H.
(2004). Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA
101: 3527-3532
[Abstract]
[Full Text]
-
Shiratori, I., Ogasawara, K., Saito, T., Lanier, L. L., Arase, H.
(2004). Activation of Natural Killer Cells and Dendritic Cells upon Recognition of a Novel CD99-like Ligand by Paired Immunoglobulin-like Type 2 Receptor. JEM
199: 525-533
[Abstract]
[Full Text]
-
Brady, J., Hayakawa, Y., Smyth, M. J., Nutt, S. L.
(2004). IL-21 Induces the Functional Maturation of Murine NK Cells. J. Immunol.
172: 2048-2058
[Abstract]
[Full Text]
-
Nieswandt, B., Watson, S. P.
(2003). Platelet-collagen interaction: is GPVI the central receptor?. Blood
102: 449-461
[Abstract]
[Full Text]
-
Tarzi, R. M., Davies, K. A, Claassens, J. W. C., Verbeek, J. S., Walport, M. J., Cook, H. T.
(2003). Both Fc{gamma} Receptor I and Fc{gamma} Receptor III Mediate Disease in Accelerated Nephrotoxic Nephritis. Am. J. Pathol.
162: 1677-1683
[Abstract]
[Full Text]
-
Arase, N., Arase, H., Hirano, S., Yokosuka, T., Sakurai, D., Saito, T.
(2003). IgE-Mediated Activation of NK Cells Through Fc{gamma}RIII. J. Immunol.
170: 3054-3058
[Abstract]
[Full Text]
-
Li, J., Rabinovich, B. A., Hurren, R., Shannon, J., Miller, R. G.
(2003). Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B. Int Immunol
15: 411-416
[Abstract]
[Full Text]
-
Ho, E. L., Carayannopoulos, L. N., Poursine-Laurent, J., Kinder, J., Plougastel, B., Smith, H. R. C., Yokoyama, W. M.
(2002). Costimulation of Multiple NK Cell Activation Receptors by NKG2D. J. Immunol.
169: 3667-3675
[Abstract]
[Full Text]
-
Arase, H., Saito, T., Phillips, J. H., Lanier, L. L.
(2001). Cutting Edge: The Mouse NK Cell-Associated Antigen Recognized by DX5 Moncoclonal Antibody is CD49b ({alpha}2 Integrin, Very Late Antigen-2). J. Immunol.
167: 1141-1144
[Abstract]
[Full Text]
-
Arase, H., Suenaga, T., Arase, N., Kimura, Y., Ito, K., Shiina, R., Ohno, H., Saito, T.
(2001). Negative Regulation of Expression and Function of Fc{{gamma}}RIII by CD3{{zeta}} in Murine NK Cells. J. Immunol.
166: 21-25
[Abstract]
[Full Text]
-
Wu, J., Cherwinski, H., Spies, T., Phillips, J. H., Lanier, L. L.
(2000). Dap10 and Dap12 Form Distinct, but Functionally Cooperative, Receptor Complexes in Natural Killer Cells. JEM
192: 1059-1068
[Abstract]
[Full Text]
-
Bonish, B., Jullien, D., Dutronc, Y., Huang, B. B., Modlin, R., Spada, F. M., Porcelli, S. A., Nickoloff, B. J.
(2000). Overexpression of CD1d by Keratinocytes in Psoriasis and CD1d-Dependent IFN-{gamma} Production by NK-T Cells. J. Immunol.
165: 4076-4085
[Abstract]
[Full Text]
-
Hamano, Y., Arase, H., Saisho, H., Saito, T.
(2000). Immune Complex and Fc Receptor-Mediated Augmentation of Antigen Presentation for in Vivo Th Cell Responses. J. Immunol.
164: 6113-6119
[Abstract]
[Full Text]
-
Smith, H. R.C., Chuang, H. H., Wang, L. L., Salcedo, M., Heusel, J. W., Yokoyama, W. M.
(2000). Nonstochastic Coexpression of Activation Receptors on Murine Natural Killer Cells. JEM
191: 1341-1354
[Abstract]
[Full Text]
-
Lanier, L. L.
(2000). Turning on Natural Killer Cells. JEM
191: 1259-1262
[Full Text]
-
Takeda, K., Oshima, H., Hayakawa, Y., Akiba, H., Atsuta, M., Kobata, T., Kobayashi, K., Ito, M., Yagita, H., Okumura, K.
(2000). CD27-Mediated Activation of Murine NK Cells. J. Immunol.
164: 1741-1745
[Abstract]
[Full Text]
-
Vance, R. E., Jamieson, A. M., Raulet, D. H.
(1999). Recognition of the Class Ib Molecule Qa-1b by Putative Activating Receptors Cd94/Nkg2c and Cd94/Nkg2e on Mouse Natural Killer Cells. JEM
190: 1801-1812
[Abstract]
[Full Text]
-
Ono, M., Yuasa, T., Ra, C., Takai, T.
(1999). Stimulatory Function of Paired Immunoglobulin-like Receptor-A in Mast Cell Line by Associating with Subunits Common to Fc Receptors. J. Biol. Chem.
274: 30288-30296
[Abstract]
[Full Text]
-
Nakaseko, C., Miyatake, S., Iida, T., Hara, S., Abe, R., Ohno, H., Saito, T.
(1999). Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Engagement Delivers an Inhibitory Signal through the Membrane-Proximal Region in the Absence of the Tyrosine Motif in the Cytoplasmic Tail. JEM
190: 765-774
[Abstract]
[Full Text]
-
Colucci, F., Turner, M., Schweighoffer, E., Guy-Grand, D., Di Bartolo, V., Salcedo, M., Tybulewicz, V. L. J., Di Santo, J. P.
(1999). Redundant Role of the Syk Protein Tyrosine Kinase in Mouse NK Cell Differentiation. J. Immunol.
163: 1769-1774
[Abstract]
[Full Text]
-
Satoskar, A. R., Stamm, L. M., Zhang, X., Satoskar, A. A., Okano, M., Terhorst, C., David, J. R., Wang, B.
(1999). Mice Lacking NK Cells Develop an Efficient Th1 Response and Control Cutaneous Leishmania major Infection. J. Immunol.
162: 6747-6754
[Abstract]
[Full Text]
-
Kung, S. K. P., Su, R.-C., Shannon, J., Miller, R. G.
(1999). The NKR-P1B Gene Product Is an Inhibitory Receptor on SJL/J NK Cells. J. Immunol.
162: 5876-5887
[Abstract]
[Full Text]
-
Carlyle, J. R., Martin, A., Mehra, A., Attisano, L., Tsui, F. W., Zuniga-Pflucker, J. C.
(1999). Mouse NKR-P1B, a Novel NK1.1 Antigen with Inhibitory Function. J. Immunol.
162: 5917-5923
[Abstract]
[Full Text]
-
Rajagopalan, S., Long, E. O.
(1999). A Human Histocompatibility Leukocyte Antigen (HLA)-G-specific Receptor Expressed on All Natural Killer Cells. JEM
189: 1093-1100
[Abstract]
[Full Text]
-
Poggi, A., Zocchi, M. R., Costa, P., Ferrero, E., Borsellino, G., Placido, R., Galgani, S., Salvetti, M., Gasperini, C., Ristori, G., Brosnan, C. F., Battistini, L.
(1999). IL-12-Mediated NKRP1A Up-Regulation and Consequent Enhancement of Endothelial Transmigration of V{delta}2+ TCR{gamma}{delta}+ T Lymphocytes from Healthy Donors and Multiple Sclerosis Patients. J. Immunol.
162: 4349-4354
[Abstract]
[Full Text]
-
Hirose, K., Suzuki, H., Nishimura, H., Mitani, A., Washizu, J., Matsuguchi, T., Yoshikai, Y.
(1998). Interleukin-15 May Be Responsible for Early Activation of Intestinal Intraepithelial Lymphocytes after Oral Infection with Listeria monocytogenes in Rats. Infect. Immun.
66: 5677-5683
[Abstract]
[Full Text]
-
Exley, M., Porcelli, S., Furman, M., Garcia, J., Balk, S.
(1998). CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant V{alpha}24J{alpha}Q T Cell Receptor {alpha} Chains. JEM
188: 867-876
[Abstract]
[Full Text]
-
Nieswandt, B., Bergmeier, W., Schulte, V., Rackebrandt, K., Gessner, J. E., Zirngibl, H.
(2000). Expression and Function of the Mouse Collagen Receptor Glycoprotein VI Is Strictly Dependent on Its Association with the FcRgamma Chain. J. Biol. Chem.
275: 23998-24002
[Abstract]
[Full Text]
Top
Abstract
Materials and Methods
